Performance that placed Fund I in the top 10% of its global vintage.
Boson Eoarchean Fund I — our predecessor fund — invested into Australian deep tech from 2021. In a cohort where 85% of peers remain at zero DPI, Fund I has already returned cash while holding 92% of its value unrealised.
A tough vintage. We outperformed the median and the top quartile.
The 2021 vintage launched into peak valuations and exited into a contracted IPO market — 85% of peers in this cohort still report zero DPI. Fund I has already begun distributing capital and ranks in the top decile of its global vintage on TVPI.
Eight investments. Lower mortality than the 2021 vintage average — and top-decile performance.
Eoarchean Fund I was sector-agnostic — first-cheque investments across fintech, SaaS, advanced manufacturing, and bio. Two write-offs out of eight is below 2021-vintage norms; six performing positions carry the fund. Boson Newton II narrows the strategy to deep tech: bio & medical, advanced manufacturing, AI & robotics.
Kite Magnetics
Kite Magnetics develops nanocrystalline soft magnetic alloys that cut electric motor losses by more than half. Their material is the missing link for the next decade of electric aviation, heavy-duty EVs, and grid-scale machines — a market the IEA puts at over US$60B by 2035.
Boson led Kite's seed round in 2022 alongside Monash University, supported the founders through Series A pricing, and brokered the introductions into the Greater China industrial-customer pipeline that now underwrites their growth thesis.
Boson Newton Fund II carries Fund I's playbook forward.
Newton II is now open to new investors. Same team. Same thesis — Australian deep tech, with structural advantages in sourcing, technical due diligence, and the Greater China commercialisation corridor. Earlier stage, larger fund, sharper sector focus.
Read about Newton Fund IIBoson Eoarchean Fund I is closed to new investors. This page describes historical performance for context only. Performance figures are unaudited, calculated per IPEV guidelines as of Q1 2026, and subject to change. 92% of value is unrealised. Past performance is not indicative of future results. Read full disclaimer.